UMP Healthcare Holdings Limited

Research UMP Healthcare Holdings Limited (0722.HK) on Bullrun: market cap HKD 324.38M, dividend yield 8.5%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is HKD 324.38M; dividend yield is 8.5%.

Peer valuation comparison

Latest dividend yield is 8.46% versus a Healthcare sector median of 2.4% (252.5% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025n/an/an/an/a0.04n/an/an/a
FY2024HKD 748.49MHKD 40.64MHKD 91.54M92.5%0.05HKD 253.35MHKD 172.57MHKD 725.94M
FY2023HKD 727.17MHKD 60.45MHKD 80.71M93.8%0.08HKD 289.13MHKD 172.22MHKD 740.55M
FY2022HKD 665.86MHKD 72.17MHKD 26.40M94.4%0.09HKD 235.73MHKD 148.34MHKD 698.65M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18HKD 324.38Mn/a7.0%0.03

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.03 HKD, yield 8.5%.

YearDividends/share
FY20250.03 HKD
FY20240.03 HKD
FY20230.05 HKD
FY20220.05 HKD

About UMP Healthcare Holdings Limited

UMP Healthcare Holdings Limited, an investment holding company, provides a range of medical and healthcare services in Hong Kong, Macau, and Mainland China. It operates in three segments, Hong Kong & Macau Corporate Healthcare Solution Services, Hong Kong & Macau Clinical Healthcare Services, and Chinese Mainland Clinical Healthcare Services. The company offers general practice and family medicine;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is UMP Healthcare Holdings Limited's market cap?

UMP Healthcare Holdings Limited's market capitalization is HKD 324.38M.

Does UMP Healthcare Holdings Limited pay a dividend?

UMP Healthcare Holdings Limited has a dividend yield of 8.5%.

What does UMP Healthcare Holdings Limited do?

UMP Healthcare Holdings Limited, an investment holding company, provides a range of medical and healthcare services in Hong Kong, Macau, and Mainland China. It operates in three segments, Hong Kong & Macau Corporate Healthcare Solution Services, Hong Kong & Macau Clinical Healthcare Services, and Chinese Mainland Clinical Healthcare Services.